Literature DB >> 9323590

Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion.

A J Mendez1.   

Abstract

It is becoming increasingly accepted that removal of cellular cholesterol occurs by at least two pathways, one involving the well-described aqueous diffusion mechanism and another promoted by lipid-free apolipoproteins. We compared the contribution of apolipoprotein-dependent and -independent pathways, taking into consideration the influence of cellular metabolism, on cholesterol efflux promoted by different extracellular acceptor types. The acceptors used were assumed to participate in only passive efflux by lipid-dependent mechanisms (phospholipid vesicles and trypsin-modified high density lipoproteins) or to stimulate efflux by apolipoprotein-dependent pathways (purified apolipoprotein A-I and high density lipoproteins). Apolipoprotein-mediated cholesterol efflux was only apparent in growth-arrested or cholesterol-enriched cells and required metabolic energy. In contrast, cholesterol efflux by apolipoprotein-depleted acceptors did not depend on cell growth state, cholesterol enrichment, or metabolic energy. Apolipoprotein-mediated efflux was not observed at temperatures below 22 degrees C, while apolipoprotein-independent efflux was only reduced by 50% at 4 degrees C compared with incubations at 37 degrees C. Additionally, apolipoproteins promoted a more rapid and larger decrease in intracellular cholesteryl esters when measured by changes in cholesteryl ester radioactivity, mass, or the pool of cholesterol available for esterification by acyl coenzyme A:cholesterol acyltransferase. Efflux of excess cellular cholesterol by an apolipoprotein-dependent pathway appears to involve specific cellular events consistent with the properties of an active transport pathway and distinguishable from cholesterol efflux by apolipoprotein-depleted acceptors through passive mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323590

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Authors:  Christopher E Pedigo; Gloria Michelle Ducasa; Farah Leclercq; Alexis Sloan; Alla Mitrofanova; Tahreem Hashmi; Judith Molina-David; Mengyuan Ge; Mariann I Lassenius; Carol Forsblom; Markku Lehto; Per-Henrik Groop; Matthias Kretzler; Sean Eddy; Sebastian Martini; Heather Reich; Patricia Wahl; GianMarco Ghiggeri; Christian Faul; George W Burke; Oliver Kretz; Tobias B Huber; Armando J Mendez; Sandra Merscher; Alessia Fornoni
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

3.  Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.

Authors:  Andrea J Luthi; Heng Zhang; Dongwoo Kim; David A Giljohann; Chad A Mirkin; C Shad Thaxton
Journal:  ACS Nano       Date:  2011-12-01       Impact factor: 15.881

4.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.

Authors:  A T Remaley; S Rust; M Rosier; C Knapper; L Naudin; C Broccardo; K M Peterson; C Koch; I Arnould; C Prades; N Duverger; H Funke; G Assman; M Dinger; M Dean; G Chimini; S Santamarina-Fojo; D S Fredrickson; P Denefle; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

5.  Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.

Authors:  A K Groen; V W Bloks; R H Bandsma; R Ottenhoff; G Chimini; F Kuipers
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.

Authors:  M Michikawa; J S Gong; Q W Fan; N Sawamura; K Yanagisawa
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  Biochemical and structural characterization of apolipoprotein A-I binding protein, a novel phosphoprotein with a potential role in sperm capacitation.

Authors:  Kula N Jha; Igor A Shumilin; Laura C Digilio; Olga Chertihin; Heping Zheng; Gerd Schmitz; Pablo E Visconti; Charles J Flickinger; Wladek Minor; John C Herr
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

8.  An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages.

Authors:  Loren E Faulkner; Stacey E Panagotopulos; Jacob D Johnson; Laura A Woollett; David Y Hui; Scott R Witting; J Nicholas Maiorano; W Sean Davidson
Journal:  J Lipid Res       Date:  2008-03-22       Impact factor: 5.922

9.  Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture.

Authors:  Hirohisa Minagawa; Jiang-Sheng Gong; Cha-Gyun Jung; Atsushi Watanabe; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito; Makoto Michikawa
Journal:  J Neurosci Res       Date:  2009-08-15       Impact factor: 4.164

10.  Probing nanoscale self-assembly of nonfluorescent small molecules inside live mammalian cells.

Authors:  Yuan Gao; Cristina Berciu; Yi Kuang; Junfeng Shi; Daniela Nicastro; Bing Xu
Journal:  ACS Nano       Date:  2013-09-25       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.